With the publication of the conclusions of the health basket committee for 2023, came significant news for the patients in Israel and also a disappointment for those that the drugs and treatments, some of them life-saving, were not approved by the government this year.
Among the happy patients who have the medicine for their illness is Ruth Ward Beshari (57) from Eilat, who was diagnosed with lung cancer in April 2022 and received treatment that activates the immune system and led to the disappearance of the tumor.
This is a treatment given to patients at an early stage and can cure a quarter of the patients.
Early treatment for breast cancer in the face.
entered the new health basket,
Many medications are out there.
Treatments that did not enter the medicine basket,
"My doctor, Dr. Moore Moscovitch from Blinson suggested that I receive immunotherapy treatment, even before the surgery to remove the tumor," said Beshari. "I underwent three treatments with Opdivo and chemotherapy before the surgery, and the tumor almost disappeared.
After the treatment, only 10% of it remained and it was surgically removed.
I went through the treatments with almost no side effects.
I am happy for other patients who are in the medical condition I was in, who will get the treatment."
The patient Ruth Vared Bershi, photo: none
Mittal Davidov (35), a mother of four, was diagnosed with breast cancer two years ago when she was pregnant with her fourth and was given early treatment for breast cancer: "As the days and hours passed, I had great concerns and prayed to receive good news from the basket committee."
"Knowing that the medicine 'Linpreza', which I and many women need, entered the basket this year made me very happy. It gives me a lot of strength to continue facing this journey. I thank from the bottom of my heart everyone who was a part of this process that may actually save the lives of many patients in Israel."
Mittal Davidov recovered from cancer thanks to the new treatment, photo: Efrat Eshel
"This is a continuous suffering"
However, there are quite a few disappointed.
"We eagerly expected that the biological drug, "Dufixant", would enter the medicine basket and make the lives of the children and boys suffering from chronic esophagitis easier, and we are disappointed to hear that the medicine did not enter the basket," says Ayala Assaf, the mother of the boy Sagi (15), who was diagnosed with chronic esophagitis ( EOE) about two years ago.
Ayala Assaf and her son, the boy Sagi, who is sick with chronic esophagitis,
"My son has suffered from the disease since the age of 5. It is difficult to describe the moments of stress and anxiety for him and the whole family, when food gets stuck," says Ayala.
"The feeling is that the esophagus does not have the movement of contraction and pushing the food down. It is a continuous suffering involving treatments that fail to balance it, invasive tests once every few weeks, a large number of visits to the emergency room and the helplessness of a boy whose entire course of life is conditioned by the disease. No matter what it is Food, even rice, or if he chews well - the food gets stuck and we all stop."
According to her, Sagi received the medicine for the first time last week as part of the private insurance.
"We don't know how long the coverage will be, and what will happen if Sagi needs other treatment? We worry and fear for the future. And I'm not only worried about my child, what will happen to all the children and boys who don't get private insurance? This is outrageous discrimination."
were we wrong
We will fix it!
If you found an error in the article, we would appreciate it if you shared it with us
